Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
12.2M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
8.98M
-
Shares change
-
-428K
-
Total reported value, excl. options
-
$13.4M
-
Value change
-
-$657K
-
Number of buys
-
21
-
Number of sells
-
-39
-
Price
-
$1.49
Significant Holders of Q32 Bio Inc. - Common stock, par value $0.0001 per share (QTTB) as of Q2 2025
80 filings reported holding QTTB - Q32 Bio Inc. - Common stock, par value $0.0001 per share as of Q2 2025.
Q32 Bio Inc. - Common stock, par value $0.0001 per share (QTTB) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.98M shares
of 12.2M outstanding shares and own 73.53% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.25M shares), Atlas Venture Life Science Advisors, LLC (2.09M shares), Carlyle Group Inc. (1.1M shares), ACORN CAPITAL ADVISORS, LLC (803K shares), Monaco Asset Management SAM (592K shares), ARCH Venture Management, LLC (320K shares), Pfizer Inc (278K shares), VANGUARD GROUP INC (269K shares), Sanofi (244K shares), and BlackRock, Inc. (179K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.